View Clinical Trial (Medical Research Study)


Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical Timolol

Signup
Browse Studies

City:   Philadelphia
State:   Pennsylvania
Zip Code:   19107
Conditions:   Sturge Weber Syndrome - Port-wine Mark
Purpose:   Primary Objective: • To assess the possible utility of topical timolol in the management of port-wine mark (PWM) in Sturge-Weber syndrome in children.
Study Summary:   Port-wine mark (PWM) represents a congenital capillary malformation,characterized by dilation and malformation of dermal capillaries that lack endothelial proliferation. It is frequently seen in the facial distribution of the trigeminal nerve. PWM persists throughout life and involves ~0.3% of the population. Although PWMs are found in other circumstances, ~ 3% of patients with facial PWM are also afflicted with Sturge-Weber syndrome. PWMs are cosmetic entities that often have serious social consequences, producing psychological trauma to both children and their parents. PWM does not involute with time, and, if left untreated, can develop deep purple coloration, tissue hypertrophy, and nodularity. Laser therapy, which selectively destroys specific targets within the skin, is currently the most commonly used approach for treating PWM, although complete blanching of the PWM after laser is rarely achieved for most patients, and only 10-45% of patients with Sturge-Weber have shown satisfactory outcomes. Complications of pulsed dye laser treatment for PWM include pyogenic granuloma, scabbing, cutaneous scarring, and permanent hypo/hyperpigmentation. Laser treatment is relatively contraindicated in children with darker skin coloration due to the resulting hypopigmentation which may be equally unsightly. Laser treatment causes substantial discomfort and pain to patients, and often requires general anesthesia in children. This is particularly true since earlier treatment in infancy is desirable and yields increased successful resolution of the PWM. The hypertrophic PWM in later years is resistant to any treatment. Recently, propranolol was reported to successfully treat capillary hemangioma in infants.13 While the mechanism by which beta blockade improves hemangioma is unclear, ß2-mediated vasoconstrictive effects and the ensuing apoptosis of capillary endothelial cells may contribute to the positive therapeutic results. Oral application of propranolol can cause severe systemic complications, including bronchospasm, vasospasm, hypoglycemia, hypotension, severe bradycardia, heart block, and congestive heart failure. Topical timolol solution, a β-blocker, has shown a similar ability to reduce capillary hemangioma of eyelids with little or no systemic effects in a small pilot study. Similar to capillary hemangioma, which is a proliferative lesion characterized by increased endothelial cell turnover, PWM is a capillary malformation with abnormal endothelial cells and large surface area of dilated capillaries. Thus, both capillary hemangioma and PWM share the similar characteristic of abnormal capillary endothelial cells. This pilot study is designed to explore the potential role of topical timolol in the management of PWM. As PWM is so frequently associated with Sturge-Weber syndrome, a disorder in which approximately 50% of patients will develop glaucoma, this study will be conducted in an ophthalmology setting. This study will consist of two arms. One group will receive timolol and the second group a placebo preservative free artificial tear gel. The groups will be divided with a ratio of 1:1 and the Timolol group will be matched with the placebo group by PWM location, age and race. Both medications are to be applied and rubbed in by fingertip to the treatment site twice a day for 6 months by subject's parents/guardian. (Treatment site: 1x1 cm at inferior edge of facial PWM) Follow-up schedule: 1 week after treatment initiation and then every 2 months for a period of six months.
Criteria:   Inclusion criteria: - Age from 2 years to 10 years - Port-Wine Mark - English fluent and literate substitute decision maker - Substitute decision maker vision sufficient to read informed consent document Exclusion criteria: - Active ocular infection (conjunctivitis, keratitis,) - History of systemic conditions including hypo/hypertension, hypoglycemia, bradycardia, asthma or any contraindication to beta blocker use - Unable to comply with required follow-up - Substitute decision maker not English fluent or not literate - Substitute decision maker unable to read consent document - Patient already using systemic beta-blocker or beta-agonist (Patients already using topical beta-blocker for glaucoma will not be excluded from study).
NCT ID:   NCT01533376
Primary Contact:   Principal Investigator
Alex V Levin, MD, MHSc
Wills Eye Institute

Jose A Cordovez, MD
Phone: 2159283418
Email: jcordovez@willseye.org
Backup Contact:   Email: alevin@willseye.org
Alex V Levin, MD, MHSc
Phone: 2159283918
Location Contact:   Philadelphia, Pennsylvania 19107
United States

Jose A Cordovez, MD
Phone: 215-928-3418
Email: jcordovez@willseye.org

Site Status: Recruiting

Data Source:   ClinicalTrials.gov
Date Processed:   May 21, 2015
Modifications to this listing:   Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


If you would like to be contacted by the clinical trial representative please enter your contact information, then click I Am Interested In This Study

Full Name:
 
Email Address:
Confirm Email:
Daytime Phone (eg. 555-555-5555):
City:
State:
Zip Code:
Best Time to Call:
Questions/Comments:
  • NEARBY STUDIES

    (updated 35 minutes ago)
Within 25 Miles

Elderly Dementia Risk - Marlton NJ

Adolescent Major Depression (Ages 12-17) - Cherry Hill NJ

Adolescent Depression - Cherry Hill NJ

Post-Traumatic Stress Disorder (PTSD) - Norristown PA

Attention Deficit Hyperactivity Disorder (ADHD) - Cherry Hill NJ

Depression - Cherry Hill NJ

Diabetic Kidney Disease - Philadelphia PA

Diabetic Kidney Disease - Philadelphia PA

Multiple Sclerosis - Philadelphia PA

COPD (Emphysema and Chronic Bronchitis) - Philadelphia PA

Anxiety - Cherry Hill NJ

Hepatitis B - Philadelphia PA

Polycystic Kidney Disease (PKD) - Autosomal Dominant (ADPKD) - Philadelphia PA

Polycystic Kidney Disease (PKD) - Autosomal Dominant (ADPKD) - Voorhees NJ

Within 50 Miles

Alzheimer’s Disease - Manchester Township NJ

Vaginal Dryness/Painful Intercourse - Plainsboro NJ

Anemia - Plainsboro NJ

Polycystic Kidney Disease (PKD) - Autosomal Dominant (ADPKD) - Bethlehem PA

Polycystic Kidney Disease (PKD) - Autosomal Dominant (ADPKD) - Doylestown PA

Diabetic Kidney Disease - Bethlehem PA

Obese Adults with Type 2 Diabetes - Trenton NJ

Kidney Problems with Type 2 Diabetes - Trenton NJ

Women With Low Sex Drive - Plainsboro NJ

Vaginal Yeast Infections - Plainsboro NJ

High Cholesterol - Downingtown PA

Eczema - Bethlehem PA

Alzheimer's Disease - Lawrenceville NJ

Alzheimer's Disease - Lawrenceville NJ

Parkinson's Disease - Lawrenceville NJ

Low Testosterone (Hypogonadism) - Lawrenceville NJ

Asthma in Children (Ages 5 to 11) - Toms River NJ

Within 100 Miles

Type 2 Diabetes and Diabetic Nephropathy (Diabetic Kidney Disease) - Eatontown NJ

Type 2 Diabetes and Diabetic Nephropathy (Diabetic Kidney Disease) - New York NY

Leukemia or Lymphoma - Bronx NY

Leukemia or Lymphoma - Hershey PA

Metastatic Pancreatic Cancer - Towson MD

Alzheimer’s Disease - Staten Island NY

Alzheimer’s Disease - Wilkes Barre PA

Elderly Dementia Risk - New York NY

Elderly Dementia Risk - New York NY

Diabetic Foot Ulcers (Sores) - Pasadena MD

Ulcerative Colitis - Great Neck NY

Crohn's Disease - Great Neck NY

Depression - New York NY

Adolescent Major Depression (Ages 12-17) - Baltimore MD

Temporomandibular Disorder (TMJD) - Baltimore MD

Postherpetic Neuralgia - New York NY

Social Anxiety Disorder - New York NY

Adult ADHD - New York NY

Depression - New York NY

Major Depression Disorder - New York NY

Treatment-Resistant Major Depressive Disorder - New York NY

Healthy Volunteers (Age 18-49) - Baltimore MD

Fibromyalgia Pain - New York NY

Polycystic Kidney Disease (PKD) - Autosomal Dominant (ADPKD) - New York NY

Polycystic Kidney Disease (PKD) - Autosomal Dominant (ADPKD) - Jamaica NY

Diabetic Kidney Disease - Eatontown NJ

Diabetic Kidney Disease - New York NY

Diabetic Kidney Disease - New York NY

Diabetic Kidney Disease - New York NY

Diabetic Kidney Disease - New Hyde Park NY

Diabetic Kidney Disease - Brooklyn NY

Diabetic Kidney Disease - Brooklyn NY

Psoriasis - New York NY

Stress Urinary Incontinence (SUI) - Glen Burnie MD

Healthy Volunteers (Age 18-65) - Baltimore MD

Adolescent Major Depression (Ages 12-17) - Neptune NJ

Polycystic Kidney Disease (PKD) - Autosomal Dominant (ADPKD) - Baltimore MD

Herpes - Towson MD

Stress Urinary Incontinence (SUI) - Great Neck NY

Healthy Volunteers (Age 18-35) - Baltimore MD

Healthy Volunteers (Age 18-45) - Baltimore MD

Allergies - Baltimore MD

Eczema - Baltimore MD

COPD (Emphysema and Chronic Bronchitis) - Great Neck NY

Heart Attack - Towson MD

Healthy Volunteers (Age 50-80) - Baltimore MD

Healthy Volunteers (Age 25-80) - Baltimore MD

Adult Autism - Baltimore MD

Adult Autism - Bronx NY

Adult Autism - New York NY

Adult Autism - Orangeburg NY

Asthma in Children (Ages 5 to 11) - Verona NJ

Depression - New York NY

COPD (Emphysema and Chronic Bronchitis) - Brooklyn NY

Acne - New York NY

Memory Loss - New York NY

Diabetic Foot Pain - New York NY

Anxiety - New York NY

Depression - New York NY

Elderly Depression - New York NY

Crohn's Disease - New York NY

Iron Deficient Anemia - New York NY

Post Menopause - Baltimore MD

Recurrent Major Depressive Disorder - New York NY

Eczema - New Hyde Park NY

Spinal Cord Injury - Baltimore MD

Healthy NON-Smokers - Catonsville MD

Osteoarthritis of the Knee - Towson MD

Premature Ejaculation - New York NY

Healthy Volunteers (Age 18-55) - Baltimore MD

Healthy Volunteers (Age 18-55) - Baltimore MD

Rheumatoid Arthritis - New York NY

HSDD (Decreased Sex Drive Woman) - New York NY

Migraine - Jamaica NY

COPD - New York NY

Healthy Volunteers (Age 18-50) - Baltimore MD

Adult ADHD - New York NY

Healthy Volunteers (Age 18-55) - Baltimore MD

Type II Diabetes - New York NY

Major Depressive Disorder - New York NY

Healthy Female Volunteers (Age 18-35) - Baltimore MD

Chronic Constipation - New York NY

Asthma in Children (Ages 5 to 11) - Asbury Park NJ

Asthma in Children (Ages 5 to 11) - White Marsh MD

Type 2 Diabetes - Hackensack NJ

Kidney problems and Type 1 Diabetes - Multiple Locations in the U.S. - Bronx NY